{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:28:15Z","timestamp":1786379295586,"version":"build-2736575974"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-026-09189-9","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:33:49Z","timestamp":1786376029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesenchymal Stem\/Stromal Cells and Their Derived Extracellular Vesicles: a Promising Therapeutic Strategy for Autoimmune Hepatitis"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0884-4235","authenticated-orcid":false,"given":"Mai","family":"Abdelgawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1038-0444","authenticated-orcid":false,"given":"Sahar","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2072-4490","authenticated-orcid":false,"given":"Amaan","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-5145","authenticated-orcid":false,"given":"Jia Xian","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0328-0023","authenticated-orcid":false,"given":"Shing Cheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"9189_CR1","doi-asserted-by":"publisher","unstructured":"Mieli-Vergani G, Vergani D, Czaja AJ et al (2018) Autoimmune hepatitis. Nat Rev Dis Primers 4. https:\/\/doi.org\/10.1038\/NRDP.2018.17","DOI":"10.1038\/NRDP.2018.17"},{"key":"9189_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/HEP.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN et al (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 72:671\u2013722. https:\/\/doi.org\/10.1002\/HEP.31065","journal-title":"Hepatology"},{"key":"9189_CR3","doi-asserted-by":"publisher","unstructured":"Gadour E (2021) Autoimmune Hepatitis: Treatment Options and Management Review. Cureus 13. https:\/\/doi.org\/10.7759\/CUREUS.15682","DOI":"10.7759\/CUREUS.15682"},{"key":"9189_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/LIV.14051","volume":"39","author":"L Harrison","year":"2019","unstructured":"Harrison L, Gleeson D (2019) Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)? Liver Int 39:610\u2013620. https:\/\/doi.org\/10.1111\/LIV.14051","journal-title":"Liver Int"},{"key":"9189_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K Sato","year":"2007","unstructured":"Sato K, Ozaki K, Oh I et al (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228\u2013234. https:\/\/doi.org\/10.1182\/blood-2006-02-002246","journal-title":"Blood"},{"key":"9189_CR6","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M et al (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619\u20134621. https:\/\/doi.org\/10.1182\/blood-2003-11-3909","journal-title":"Blood"},{"key":"9189_CR7","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815\u20131822. https:\/\/doi.org\/10.1182\/blood-2004-04-1559","journal-title":"Blood"},{"key":"9189_CR8","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1089\/ten.2006.12.2263","volume":"12","author":"P Batten","year":"2006","unstructured":"Batten P, Sarathchandra P, Antoniw JW et al (2006) Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng 12:2263\u20132273. https:\/\/doi.org\/10.1089\/ten.2006.12.2263","journal-title":"Tissue Eng"},{"key":"9189_CR9","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/STEM.118","volume":"27","author":"G Ren","year":"2009","unstructured":"Ren G, Su J, Zhang L et al (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27:1954\u20131962. https:\/\/doi.org\/10.1002\/STEM.118","journal-title":"Stem Cells"},{"key":"9189_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/J.SCR.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res 4:214\u2013222. https:\/\/doi.org\/10.1016\/J.SCR.2009.12.003","journal-title":"Stem Cell Res"},{"key":"9189_CR11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1681\/ASN.2008070798","volume":"20","author":"S Bruno","year":"2009","unstructured":"Bruno S, Grange C, Deregibus MC et al (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053\u20131067. https:\/\/doi.org\/10.1681\/ASN.2008070798","journal-title":"J Am Soc Nephrol"},{"key":"9189_CR12","first-page":"402","volume":"72","author":"J Primo","year":"2009","unstructured":"Primo J, Maroto N, Mart\u00ednez M et al (2009) Incidence of adult form of autoimmune hepatitis in Valencia (Spain). Acta Gastroenterol Belg 72:402\u2013406","journal-title":"Acta Gastroenterol Belg"},{"key":"9189_CR13","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1080\/00365520802130183","volume":"43","author":"M Werner","year":"2008","unstructured":"Werner M, Prytz H, Ohlsson B et al (2008) Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol 43:1232\u20131240. https:\/\/doi.org\/10.1080\/00365520802130183","journal-title":"Scand J Gastroenterol"},{"key":"9189_CR14","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/J.1440-1746.2010.06384.X","volume":"25","author":"JH Ngu","year":"2010","unstructured":"Ngu JH, Bechly K, Chapman BA et al (2010) Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 25:1681\u20131686. https:\/\/doi.org\/10.1111\/J.1440-1746.2010.06384.X","journal-title":"J Gastroenterol Hepatol"},{"key":"9189_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/J.JHEP.2013.10.020","volume":"60","author":"L Gr\u00f8nb\u00e6k","year":"2014","unstructured":"Gr\u00f8nb\u00e6k L, Vilstrup H, Jepsen P (2014) Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol 60:612\u2013617. https:\/\/doi.org\/10.1016\/J.JHEP.2013.10.020","journal-title":"J Hepatol"},{"key":"9189_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/J.DLD.2019.01.015","volume":"51","author":"L Puustinen","year":"2019","unstructured":"Puustinen L, Barner-Rasmussen N, Pukkala E, F\u00e4rkkil\u00e4 M (2019) Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland. Dig Liver Dis 51:1294\u20131299. https:\/\/doi.org\/10.1016\/J.DLD.2019.01.015","journal-title":"Dig Liver Dis"},{"key":"9189_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","volume":"6","author":"K Muri Boberg","year":"2002","unstructured":"Muri Boberg K (2002) Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 6:635\u2013647. https:\/\/doi.org\/10.1016\/S1089-3261(02)00021-1","journal-title":"Clin Liver Dis"},{"key":"9189_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/MCG.0000000000001449","volume":"55","author":"NA Tunio","year":"2021","unstructured":"Tunio NA, Mansoor E, Sheriff MZ et al (2021) Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019: A Population-based National Study. J Clin Gastroenterol 55:903\u2013910. https:\/\/doi.org\/10.1097\/MCG.0000000000001449","journal-title":"J Clin Gastroenterol"},{"key":"9189_CR19","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/JGH.14746","volume":"34","author":"T Lv","year":"2019","unstructured":"Lv T, Li M, Zeng N et al (2019) Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol 34:1676\u20131684. https:\/\/doi.org\/10.1111\/JGH.14746","journal-title":"J Gastroenterol Hepatol"},{"key":"9189_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938. https:\/\/doi.org\/10.1016\/S0168-8278(99)80297-9","journal-title":"J Hepatol"},{"key":"9189_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature22329","volume":"545","author":"JD Ooi","year":"2017","unstructured":"Ooi JD, Petersen J, Tan YH et al (2017) Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature 545:243\u2013247. https:\/\/doi.org\/10.1038\/nature22329","journal-title":"Nature"},{"key":"9189_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/s0140-6736(95)91438-2","volume":"346","author":"S Vento","year":"1995","unstructured":"Vento S, Guella L, Mirandola F et al (1995) Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 346:608\u2013609. https:\/\/doi.org\/10.1016\/s0140-6736(95)91438-2","journal-title":"Lancet"},{"key":"9189_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15403\/jgld.2014.1121.251.hpe","volume":"25","author":"NMF van Gerven","year":"2016","unstructured":"van Gerven NMF, van der Eijk AA, Pas SD et al (2016) Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands. J Gastrointestin Liver Dis 25:9\u201313. https:\/\/doi.org\/10.15403\/jgld.2014.1121.251.hpe","journal-title":"J Gastrointestin Liver Dis"},{"key":"9189_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/gut.2006.111864","volume":"56","author":"G Singh","year":"2007","unstructured":"Singh G, Palaniappan S, Rotimi O, Hamlin PJ (2007) Autoimmune hepatitis triggered by hepatitis A. Gut 56:304","journal-title":"Gut"},{"key":"9189_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","volume":"147","author":"YS de Boer","year":"2014","unstructured":"de Boer YS, van Gerven NMF, Zwiers A et al (2014) Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology 147:443\u201352e5. https:\/\/doi.org\/10.1053\/j.gastro.2014.04.022","journal-title":"Gastroenterology"},{"key":"9189_CR26","doi-asserted-by":"publisher","first-page":"e0187325","DOI":"10.1371\/journal.pone.0187325","volume":"12","author":"S Oka","year":"2017","unstructured":"Oka S, Furukawa H, Yasunami M et al (2017) HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4\/DR8 heterozygous genotype. PLoS ONE 12:e0187325. https:\/\/doi.org\/10.1371\/journal.pone.0187325","journal-title":"PLoS ONE"},{"key":"9189_CR27","doi-asserted-by":"publisher","first-page":"11924","DOI":"10.1038\/s41598-018-30406-9","volume":"8","author":"T Yamazaki","year":"2018","unstructured":"Yamazaki T, Umemura T, Joshita S et al (2018) A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis. Sci Rep 8:11924. https:\/\/doi.org\/10.1038\/s41598-018-30406-9","journal-title":"Sci Rep"},{"key":"9189_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s10038-018-0440-0","volume":"63","author":"S Oka","year":"2018","unstructured":"Oka S, Higuchi T, Furukawa H et al (2018) Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population. J Hum Genet 63:739\u2013744. https:\/\/doi.org\/10.1038\/s10038-018-0440-0","journal-title":"J Hum Genet"},{"key":"9189_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhepr.2019.09.003","volume":"1","author":"T Umemura","year":"2019","unstructured":"Umemura T, Joshita S, Saito H et al (2019) KIR\/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis. JHEP Rep 1:353\u2013360. https:\/\/doi.org\/10.1016\/j.jhepr.2019.09.003","journal-title":"JHEP Rep"},{"key":"9189_CR30","doi-asserted-by":"publisher","unstructured":"Krawitt EL (2006) Autoimmune Hepatitis.\u00a0N Engl J Med 354:54\u201366. https:\/\/doi.org\/10.1056\/NEJMRA050408","DOI":"10.1056\/NEJMRA050408"},{"key":"9189_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","volume":"2","author":"WR Kessler","year":"2004","unstructured":"Kessler WR, Cummings OW, Eckert G et al (2004) Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2:625\u2013631. https:\/\/doi.org\/10.1016\/S1542-3565(04)00246-0","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9189_CR32","first-page":"175","volume":"14","author":"NAS Muttaqillah","year":"2015","unstructured":"Muttaqillah NAS, Abdul Wahab A, Ding CH et al (2015) Presence of anti-mitochondrial antibodies and elevated serum immunoglobulin G levels: is this primary biliary cirrhosis-autoimmune hepatitis overlap syndrome? EXCLI J 14:175\u2013178","journal-title":"EXCLI J"},{"key":"9189_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/WJG.V21.I1.60","volume":"21","author":"NK Gatselis","year":"2015","unstructured":"Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN (2015) Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 21:60\u201383. https:\/\/doi.org\/10.3748\/WJG.V21.I1.60","journal-title":"World J Gastroenterol"},{"key":"9189_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","volume":"66","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Baumann U et al (2018) Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr 66:345\u2013360. https:\/\/doi.org\/10.1097\/MPG.0000000000001801","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9189_CR35","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/HEP.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD et al (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51:2193\u20132213. https:\/\/doi.org\/10.1002\/HEP.23584","journal-title":"Hepatology"},{"key":"9189_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4254\/WJH.V9.I1.57","volume":"9","author":"Y Torisu","year":"2017","unstructured":"Torisu Y, Nakano M, Takano K et al (2017) Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis. World J Hepatol 9:57. https:\/\/doi.org\/10.4254\/WJH.V9.I1.57","journal-title":"World J Hepatol"},{"key":"9189_CR37","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","volume":"66","author":"E Prados","year":"1998","unstructured":"Prados E, Cuervas-Mons V, de la Mata M et al (1998) Outcome of autoimmune hepatitis after liver transplantation. Transplantation 66:1645\u20131650. https:\/\/doi.org\/10.1097\/00007890-199812270-00013","journal-title":"Transplantation"},{"key":"9189_CR38","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1016\/s0041-1345(02)03570-4","volume":"34","author":"TG Heffron","year":"2002","unstructured":"Heffron TG, Smallwood GA, Oakley B et al (2002) Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid weaning. Transpl Proc 34:3311\u20133312. https:\/\/doi.org\/10.1016\/s0041-1345(02)03570-4","journal-title":"Transpl Proc"},{"key":"9189_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1440-1746.2002.02632.x","volume":"17","author":"IF Yusoff","year":"2002","unstructured":"Yusoff IF, House AK, De Boer WB et al (2002) Disease recurrence after liver transplantation in Western Australia. J Gastroenterol Hepatol 17:203\u2013207. https:\/\/doi.org\/10.1046\/j.1440-1746.2002.02632.x","journal-title":"J Gastroenterol Hepatol"},{"key":"9189_CR40","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/GUT.52.6.893","volume":"52","author":"JC Duclos-Vall\u00e9e","year":"2003","unstructured":"Duclos-Vall\u00e9e JC, Sebagh M, Rifai K et al (2003) A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 52:893\u2013897. https:\/\/doi.org\/10.1136\/GUT.52.6.893","journal-title":"Gut"},{"key":"9189_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz EM, Le Blanc K, Dominici M et al (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393\u2013395. https:\/\/doi.org\/10.1080\/14653240500319234","journal-title":"Cytotherapy"},{"key":"9189_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"key":"9189_CR43","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Shi Y, Galipeau J et al (2019) Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT\u00ae) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy 21:1019\u20131024. https:\/\/doi.org\/10.1016\/j.jcyt.2019.08.002","journal-title":"Cytotherapy"},{"key":"9189_CR44","doi-asserted-by":"publisher","unstructured":"Huang Y, Wu Q, Tam PKH (2022) Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/IJMS231710023","DOI":"10.3390\/IJMS231710023"},{"key":"9189_CR45","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/S12015-023-10539-9\/TABLES\/2","volume":"19","author":"G Yang","year":"2023","unstructured":"Yang G, Fan X, Liu Y et al (2023) Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells. Stem Cell Rev Rep 19:1214\u20131231. https:\/\/doi.org\/10.1007\/S12015-023-10539-9\/TABLES\/2","journal-title":"Stem Cell Rev Rep"},{"key":"9189_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou M, Huang L, Yang J et al (2022) Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Disease 2022 13:7. https:\/\/doi.org\/10.1038\/s41419-022-05034-x","journal-title":"Cell Death Disease 2022"},{"key":"9189_CR47","doi-asserted-by":"publisher","unstructured":"Han Y, Yang J, Fang J et al (2022) The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduction and Targeted Therapy 2022 7:1 7:92-. https:\/\/doi.org\/10.1038\/s41392-022-00932-0","DOI":"10.1038\/s41392-022-00932-0"},{"key":"9189_CR48","doi-asserted-by":"publisher","unstructured":"Li P, Ou Q, Shi S, Shao C (2023) Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications. Cellular & Molecular Immunology 2023 20:6 20:558\u2013569. https:\/\/doi.org\/10.1038\/s41423-023-00998-y","DOI":"10.1038\/s41423-023-00998-y"},{"key":"9189_CR49","doi-asserted-by":"publisher","first-page":"1094685","DOI":"10.3389\/fimmu.2023.1094685","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Wei Q, Lu L et al (2023) Immunomodulatory potential of mesenchymal stem cell-derived extracellular vesicles: Targeting immune cells. Front Immunol 14:1094685. https:\/\/doi.org\/10.3389\/FIMMU.2023.1094685\/FULL","journal-title":"Front Immunol"},{"key":"9189_CR50","doi-asserted-by":"publisher","first-page":"416500","DOI":"10.3389\/FIMMU.2018.02538\/TEXT","volume":"9","author":"M Reis","year":"2018","unstructured":"Reis M, Mavin E, Nicholson L et al (2018) Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function. Front Immunol 9:416500. https:\/\/doi.org\/10.3389\/FIMMU.2018.02538\/TEXT","journal-title":"Front Immunol"},{"key":"9189_CR51","doi-asserted-by":"publisher","unstructured":"Klyucherev TO, Yurkanova MD, Revokatova DP et al (2026) Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Pro-Inflammatory Macrophage Polarization: Comparison of Matrix-Bound and Small Extracellular Vesicles. Cells 15. https:\/\/doi.org\/10.3390\/CELLS15020093","DOI":"10.3390\/CELLS15020093"},{"issue":"1 11","key":"9189_CR52","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1038\/s41598-021-87153-7","volume":"2021 11","author":"A Haghighitalab","year":"2021","unstructured":"Haghighitalab A, Matin MM, Amin A et al (2021) Investigating the effects of IDO1, PTGS2, and TGF-\u03b21 overexpression on immunomodulatory properties of hTERT-MSCs and their extracellular vesicles. Sci Rep 2021 11(1 11):7825\u2013. https:\/\/doi.org\/10.1038\/s41598-021-87153-7","journal-title":"Sci Rep"},{"key":"9189_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/STEM.2730","volume":"36","author":"MT Harting","year":"2018","unstructured":"Harting MT, Srivastava AK, Zhaorigetu S et al (2018) Inflammation-Stimulated Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Inflammation. Stem Cells 36:79\u201390. https:\/\/doi.org\/10.1002\/STEM.2730","journal-title":"Stem Cells"},{"key":"9189_CR54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/S13287-024-03998-5","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Chen L, Yu J et al (2024) Advances in the roles and mechanisms of mesenchymal stem cell derived microRNAs on periodontal tissue regeneration. Stem Cell Res Ther 15:393. https:\/\/doi.org\/10.1186\/S13287-024-03998-5","journal-title":"Stem Cell Res Ther"},{"key":"9189_CR55","doi-asserted-by":"publisher","first-page":"102715","DOI":"10.1016\/J.OMTN.2025.102715","volume":"36","author":"Y Shahsavandi","year":"2025","unstructured":"Shahsavandi Y, Banaeian F, Jafarinia M et al (2025) miRNAs from mesenchymal-stem-cell-derived extracellular vesicles: Emerging players in regenerative medicine and disease therapy. Mol Ther Nucleic Acids 36:102715. https:\/\/doi.org\/10.1016\/J.OMTN.2025.102715","journal-title":"Mol Ther Nucleic Acids"},{"key":"9189_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2025.2512618","volume":"22","author":"YJ Lim","year":"2025","unstructured":"Lim YJ, Seo MS, Park WT et al (2025) Extracellular vesicle-derived MicroRNAs as potential therapies for spinal cord and peripheral nerve injuries. RNA Biol 22:1\u20139. https:\/\/doi.org\/10.1080\/15476286.2025.2512618","journal-title":"RNA Biol"},{"key":"9189_CR57","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCRESAHA.117.309681","volume":"120","author":"D Todorova","year":"2017","unstructured":"Todorova D, Simoncini S, Lacroix R et al (2017) Extracellular Vesicles in Angiogenesis. Circ Res 120:1658\u20131673. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309681","journal-title":"Circ Res"},{"key":"9189_CR58","doi-asserted-by":"publisher","unstructured":"Yudintceva N, Mikhailova N, Fedorov V et al (2022) Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice. Bioeng (Basel) 9. https:\/\/doi.org\/10.3390\/BIOENGINEERING9110662","DOI":"10.3390\/BIOENGINEERING9110662"},{"key":"9189_CR59","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/adhm.201600308","volume":"5","author":"KR Vrijsen","year":"2016","unstructured":"Vrijsen KR, Maring JA, Chamuleau SAJ et al (2016) Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN. Adv Healthc Mater 5:2555\u20132565. https:\/\/doi.org\/10.1002\/adhm.201600308","journal-title":"Adv Healthc Mater"},{"key":"9189_CR60","first-page":"4289","volume":"8","author":"X Zou","year":"2016","unstructured":"Zou X, Gu D, Xing X et al (2016) Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats. Am J Transl Res 8:4289\u20134299","journal-title":"Am J Transl Res"},{"issue":"1","key":"9189_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15376-8","volume":"7","author":"S Cosenza","year":"2017","unstructured":"Cosenza S, Ruiz M, Toupet K et al (2017) Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep 2017 7(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-017-15376-8","journal-title":"Sci Rep 2017"},{"key":"9189_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/STCLTM\/SZAD086","volume":"13","author":"J Redondo","year":"2023","unstructured":"Redondo J, Bailey S, Kemp KC et al (2023) The Bone Marrow Microenvironment in Immune-Mediated Inflammatory Diseases: Implications for Mesenchymal Stromal Cell-Based Therapies. Stem Cells Transl Med 13:219. https:\/\/doi.org\/10.1093\/STCLTM\/SZAD086","journal-title":"Stem Cells Transl Med"},{"key":"9189_CR63","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.imlet.2014.10.021","volume":"162","author":"Y Chen","year":"2014","unstructured":"Chen Y, Chen S, Liu L-Y et al (2014) Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway. Immunol Lett 162:222\u2013228. https:\/\/doi.org\/10.1016\/j.imlet.2014.10.021","journal-title":"Immunol Lett"},{"key":"9189_CR64","doi-asserted-by":"publisher","first-page":"e45272","DOI":"10.1371\/journal.pone.0045272","volume":"7","author":"P Luz-Crawford","year":"2012","unstructured":"Luz-Crawford P, No\u00ebl D, Fernandez X et al (2012) Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway. PLoS ONE 7:e45272. https:\/\/doi.org\/10.1371\/journal.pone.0045272","journal-title":"PLoS ONE"},{"key":"9189_CR65","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y et al (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027\u20131034. https:\/\/doi.org\/10.1084\/jem.192.7.1027","journal-title":"J Exp Med"},{"key":"9189_CR66","doi-asserted-by":"publisher","first-page":"982238","DOI":"10.3389\/FPHAR.2022.982238\/FULL","volume":"13","author":"DK Xiong","year":"2022","unstructured":"Xiong DK, Shi X, Han MM et al (2022) The regulatory mechanism and potential application of IL-23 in autoimmune diseases. Front Pharmacol 13:982238. https:\/\/doi.org\/10.3389\/FPHAR.2022.982238\/FULL","journal-title":"Front Pharmacol"},{"key":"9189_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233\u2013240. https:\/\/doi.org\/10.1084\/jem.20041257","journal-title":"J Exp Med"},{"key":"9189_CR68","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.26355\/EURREV_202102_24870","volume":"25","author":"ZK Chen","year":"2021","unstructured":"Chen ZK, Chen DZ, Cai C et al (2021) BMSCs attenuate hepatic fibrosis in autoimmune hepatitis through regulation of LMO7-AP1-TGF\u03b2 signaling pathway. Eur Rev Med Pharmacol Sci 25:1600\u20131611. https:\/\/doi.org\/10.26355\/EURREV_202102_24870","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9189_CR69","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/CIRCULATIONAHA.118.034615","volume":"139","author":"Y Xie","year":"2019","unstructured":"Xie Y, Ostriker AC, Jin Y et al (2019) LMO7 is a negative feedback regulator of TGF-\u03b2 signaling and fibrosis. Circulation 139:679\u2013693. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034615","journal-title":"Circulation"},{"key":"9189_CR70","doi-asserted-by":"publisher","first-page":"e0269","DOI":"10.1097\/HC9.0000000000000269","volume":"7","author":"H Chen","year":"2023","unstructured":"Chen H, Han Z, Fan Y et al (2023) CD4\u2009+\u2009T-cell subsets in autoimmune hepatitis: A review. Hepatol Commun 7:e0269. https:\/\/doi.org\/10.1097\/HC9.0000000000000269","journal-title":"Hepatol Commun"},{"key":"9189_CR71","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-012-1524-3","volume":"351","author":"X Zhu","year":"2013","unstructured":"Zhu X, He B, Zhou X, Ren J (2013) Effects of transplanted bone-marrow-derived mesenchymal stem cells in animal models of acute hepatitis. Cell Tissue Res 351:477\u2013486. https:\/\/doi.org\/10.1007\/s00441-012-1524-3","journal-title":"Cell Tissue Res"},{"key":"9189_CR72","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/SCD.2010.0246","volume":"20","author":"N Wada","year":"2011","unstructured":"Wada N, Bartold PM, Gronthos S (2011) Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal\/stem cells. Stem Cells Dev 20:647\u2013659. https:\/\/doi.org\/10.1089\/SCD.2010.0246","journal-title":"Stem Cells Dev"},{"key":"9189_CR73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.62940\/ALS.V12I1.3171","volume":"12","author":"N Sultan","year":"2025","unstructured":"Sultan N, Ramadhan WS, Alkarim S (2025) Bone marrow-derived mesenchymal stem cells: a potential therapy in an autoimmune hepatitis rat model. Adv Life Sci 12:105\u2013113. https:\/\/doi.org\/10.62940\/ALS.V12I1.3171","journal-title":"Adv Life Sci"},{"issue":"1 13","key":"9189_CR74","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/S13287-022-02822-2","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Jiang Y, Hou Q et al (2022) Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects. Stem Cell Res Therapy 2022 13(1 13):146\u2013. https:\/\/doi.org\/10.1186\/S13287-022-02822-2","journal-title":"Stem Cell Res Therapy 2022"},{"key":"9189_CR75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/hum.2017.171","volume":"29","author":"W Wang","year":"2018","unstructured":"Wang W, Guo H, Li H et al (2018) Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level. Hum Gene Ther 29:234\u2013241. https:\/\/doi.org\/10.1089\/hum.2017.171","journal-title":"Hum Gene Ther"},{"key":"9189_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/JIR.2021.0147","volume":"41","author":"C Ye","year":"2021","unstructured":"Ye C, Yano H, Workman CJ, Vignali DAA (2021) Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases. J Interferon Cytokine Res 41:391\u2013406. https:\/\/doi.org\/10.1089\/JIR.2021.0147","journal-title":"J Interferon Cytokine Res"},{"key":"9189_CR77","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/HUM.2017.171","volume":"29","author":"W Wang","year":"2018","unstructured":"Wang W, Guo H, Li H et al (2018) Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level. Hum Gene Ther 29:234\u2013241. https:\/\/doi.org\/10.1089\/HUM.2017.171;CTYPE:STRING:JOURNAL","journal-title":"Hum Gene Ther"},{"key":"9189_CR78","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.4252\/wjsc.v12.i12.1623","volume":"12","author":"Y-K Zhou","year":"2020","unstructured":"Zhou Y-K, Zhu L-S, Huang H-M et al (2020) Stem cells from human exfoliated deciduous teeth ameliorate concanavalin A-induced autoimmune hepatitis by protecting hepatocytes from apoptosis. World J Stem Cells 12:1623. https:\/\/doi.org\/10.4252\/wjsc.v12.i12.1623","journal-title":"World J Stem Cells"},{"key":"9189_CR79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yexcr.2014.06.007","volume":"326","author":"K-H Ryu","year":"2014","unstructured":"Ryu K-H, Kim S-Y, Kim Y-R et al (2014) Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury. Exp Cell Res 326:143\u2013154. https:\/\/doi.org\/10.1016\/j.yexcr.2014.06.007","journal-title":"Exp Cell Res"},{"key":"9189_CR80","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar2459","volume":"10","author":"S Janjanin","year":"2008","unstructured":"Janjanin S, Djouad F, Shanti RM et al (2008) Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells. Arthritis Res Ther 10:R83. https:\/\/doi.org\/10.1186\/ar2459","journal-title":"Arthritis Res Ther"},{"key":"9189_CR81","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","volume":"116","author":"F Gieseke","year":"2010","unstructured":"Gieseke F, B\u00f6hringer J, Bussolari R et al (2010) Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116:3770\u20133779. https:\/\/doi.org\/10.1182\/blood-2010-02-270777","journal-title":"Blood"},{"key":"9189_CR82","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1159\/000501684","volume":"84","author":"SC Tan","year":"2019","unstructured":"Tan SC (2019) Use of Arbitrary Reference Genes May Lead to Misleading Conclusions. Gynecol Obstet Invest 84:519\u2013520","journal-title":"Gynecol Obstet Invest"},{"key":"9189_CR83","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/07357907.2017.1278767","volume":"35","author":"SC Tan","year":"2017","unstructured":"Tan SC, Ismail MP, Duski DR et al (2017) Identification of Optimal Reference Genes for Normalization of RT-qPCR Data in Cancerous and Non-Cancerous Tissues of Human Uterine Cervix. Cancer Invest 35:163\u2013173. https:\/\/doi.org\/10.1080\/07357907.2017.1278767","journal-title":"Cancer Invest"},{"key":"9189_CR84","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/eji.201343531","volume":"43","author":"M Higashimoto","year":"2013","unstructured":"Higashimoto M, Sakai Y, Takamura M et al (2013) Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4\u2009+\u2009T-cell suppression. Eur J Immunol 43:2956\u20132968. https:\/\/doi.org\/10.1002\/eji.201343531","journal-title":"Eur J Immunol"},{"key":"9189_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1440-1746.2011.06798.x","volume":"27","author":"N Kubo","year":"2012","unstructured":"Kubo N, Narumi S, Kijima H et al (2012) Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A. J Gastroenterol Hepatol 27:165\u2013172. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06798.x","journal-title":"J Gastroenterol Hepatol"},{"key":"9189_CR86","doi-asserted-by":"publisher","unstructured":"Wei X, Cheng X, Luo Y, Li X (2023) Umbilical Cord-Derived Mesenchymal Stem Cells Attenuate S100-Induced Autoimmune Hepatitis via Modulating Th1 and Th17 Cell Responses in Mice. Stem Cells Int 2023. https:\/\/doi.org\/10.1155\/2023\/9992207","DOI":"10.1155\/2023\/9992207"},{"key":"9189_CR87","doi-asserted-by":"publisher","first-page":"e0337060","DOI":"10.1371\/JOURNAL.PONE.0337060","volume":"20","author":"Y Li","year":"2025","unstructured":"Li Y, Liu B, Hu G et al (2025) Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis. PLoS ONE 20:e0337060. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0337060","journal-title":"PLoS ONE"},{"key":"9189_CR88","doi-asserted-by":"publisher","first-page":"690","DOI":"10.23736\/S0375-9393.23.17265-8","volume":"89","author":"A Sitbon","year":"2023","unstructured":"Sitbon A, Delmotte PR, Goumard C et al (2023) Therapeutic potentials of mesenchymal stromal cells-derived extracellular vesicles in liver failure and marginal liver graft rehabilitation: a scoping review. CMAJ Can Med Association J 89:690\u2013706. https:\/\/doi.org\/10.23736\/S0375-9393.23.17265-8","journal-title":"CMAJ Can Med Association J"},{"key":"9189_CR89","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41232-016-0030-5","volume":"36","author":"R Tamura","year":"2016","unstructured":"Tamura R, Uemoto S, Tabata Y (2016) Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model. Inflamm Regen 36:26. https:\/\/doi.org\/10.1186\/s41232-016-0030-5","journal-title":"Inflamm Regen"},{"key":"9189_CR90","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/hep.22395","volume":"48","author":"Q You","year":"2008","unstructured":"You Q, Cheng L, Kedl RM, Ju C (2008) Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 48:978\u2013990. https:\/\/doi.org\/10.1002\/hep.22395","journal-title":"Hepatology"},{"key":"9189_CR91","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0002-9440(10)64804-3","volume":"157","author":"J Sch\u00fcmann","year":"2000","unstructured":"Sch\u00fcmann J, Wolf D, Pahl A et al (2000) Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 157:1671\u20131683. https:\/\/doi.org\/10.1016\/S0002-9440(10)64804-3","journal-title":"Am J Pathol"},{"key":"9189_CR92","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/hep.21498","volume":"45","author":"A Erhardt","year":"2007","unstructured":"Erhardt A, Biburger M, Papadopoulos T, Tiegs G (2007) IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45:475\u2013485. https:\/\/doi.org\/10.1002\/hep.21498","journal-title":"Hepatology"},{"key":"9189_CR93","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/nm.2542","volume":"17","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang L, Kikuiri T et al (2011) Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-\u03b3 and TNF-\u03b1. Nat Med 17:1594\u20131601. https:\/\/doi.org\/10.1038\/nm.2542","journal-title":"Nat Med"},{"key":"9189_CR94","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13287-015-0071-8","volume":"6","author":"JF Evans","year":"2015","unstructured":"Evans JF, Salvador V, George S et al (2015) Mouse aorta-derived mesenchymal progenitor cells contribute to and enhance the immune response of macrophage cells under inflammatory conditions. Stem Cell Res Ther 6:56. https:\/\/doi.org\/10.1186\/s13287-015-0071-8","journal-title":"Stem Cell Res Ther"},{"key":"9189_CR95","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/stem.651","volume":"29","author":"MA Cassatella","year":"2011","unstructured":"Cassatella MA, Mosna F, Micheletti A et al (2011) Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils. Stem Cells 29:1001\u20131011. https:\/\/doi.org\/10.1002\/stem.651","journal-title":"Stem Cells"},{"key":"9189_CR96","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.2147\/IJN.S472086","volume":"19","author":"M Shen","year":"2024","unstructured":"Shen M, Zhou L, Fan X et al (2024) Metabolic Reprogramming of CD4\u2009+\u2009T Cells by Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuates Autoimmune Hepatitis Through Mitochondrial Protein Transfer. Int J Nanomed 19:9799\u20139819. https:\/\/doi.org\/10.2147\/IJN.S472086","journal-title":"Int J Nanomed"},{"key":"9189_CR97","doi-asserted-by":"publisher","first-page":"650376","DOI":"10.3389\/fbioe.2021.650376","volume":"9","author":"J Zhao","year":"2021","unstructured":"Zhao J, Li Y, Jia R et al (2021) Mesenchymal Stem Cells-Derived Exosomes as Dexamethasone Delivery Vehicles for Autoimmune Hepatitis Therapy. Front Bioeng Biotechnol 9:650376. https:\/\/doi.org\/10.3389\/fbioe.2021.650376","journal-title":"Front Bioeng Biotechnol"},{"key":"9189_CR98","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","volume":"93","author":"L Chen","year":"2018","unstructured":"Chen L, Lu F, Chen D et al (2018) BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol 93:38\u201346. https:\/\/doi.org\/10.1016\/j.molimm.2017.11.008","journal-title":"Mol Immunol"},{"key":"9189_CR99","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.4049\/jimmunol.1201516","volume":"189","author":"F Bauernfeind","year":"2012","unstructured":"Bauernfeind F, Rieger A, Schildberg FA et al (2012) NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223. J Immunol 189:4175\u20134181. https:\/\/doi.org\/10.4049\/jimmunol.1201516","journal-title":"J Immunol"},{"key":"9189_CR100","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nature06607","volume":"451","author":"JB Johnnidis","year":"2008","unstructured":"Johnnidis JB, Harris MH, Wheeler RT et al (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451:1125\u20131129. https:\/\/doi.org\/10.1038\/nature06607","journal-title":"Nature"},{"key":"9189_CR101","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/cr.2010.134","volume":"20","author":"W Sun","year":"2010","unstructured":"Sun W, Shen W, Yang S et al (2010) miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-\u03b2. Cell Res 20:1158\u20131169. https:\/\/doi.org\/10.1038\/cr.2010.134","journal-title":"Cell Res"},{"key":"9189_CR102","doi-asserted-by":"publisher","first-page":"906","DOI":"10.14348\/molcells.2019.2283","volume":"42","author":"F-B Lu","year":"2019","unstructured":"Lu F-B, Chen D-Z, Chen L et al (2019) Attenuation of Experimental Autoimmune Hepatitis in Mice with Bone Mesenchymal Stem Cell-Derived Exosomes Carrying MicroRNA-223-3p. Mol Cells 42:906\u2013918. https:\/\/doi.org\/10.14348\/molcells.2019.2283","journal-title":"Mol Cells"},{"key":"9189_CR103","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3389\/fimmu.2020.02026","volume":"11","author":"D Dou","year":"2020","unstructured":"Dou D, Ren X, Han M et al (2020) Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92\/PD-L1 Pathway. Front Immunol 11:2026. https:\/\/doi.org\/10.3389\/fimmu.2020.02026","journal-title":"Front Immunol"},{"key":"9189_CR104","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12026-018-9008-5","volume":"66","author":"M Azimi","year":"2018","unstructured":"Azimi M, Ghabaee M, Moghadasi AN et al (2018) Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis. Immunol Res 66:513\u2013520. https:\/\/doi.org\/10.1007\/s12026-018-9008-5","journal-title":"Immunol Res"},{"key":"9189_CR105","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1158\/1078-0432.CCR-08-2715","volume":"15","author":"W Wu","year":"2009","unstructured":"Wu W, Zhang W, Qiao R et al (2009) Association of XPD Polymorphisms with Severe Toxicity in Non-Small Cell Lung Cancer Patients in a Chinese Population. Clin Cancer Res 15:3889\u20133895. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2715","journal-title":"Clin Cancer Res"},{"key":"9189_CR106","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-019-1075-2","volume":"18","author":"L-Q Cao","year":"2019","unstructured":"Cao L-Q, Yang X-W, Chen Y-B et al (2019) Exosomal miR-21 regulates the TETs\/PTENp1\/PTEN pathway to promote hepatocellular carcinoma growth. Mol Cancer 18:148. https:\/\/doi.org\/10.1186\/s12943-019-1075-2","journal-title":"Mol Cancer"},{"key":"9189_CR107","doi-asserted-by":"publisher","unstructured":"Gupta D, Wiklander OPB, Wood MJA, El-Andaloussi S (2023) Biodistribution of therapeutic extracellular vesicles. Extracell Vesicles Circ Nucleic Acids 2023;4:170\u2009\u2013\u200990 4:170\u2013190. https:\/\/doi.org\/10.20517\/EVCNA.2023.12","DOI":"10.20517\/EVCNA.2023.12"},{"key":"9189_CR108","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jconrel.2023.07.059","volume":"361","author":"Y Ma","year":"2023","unstructured":"Ma Y, Brocchini S, Williams GR (2023) Extracellular vesicle-embedded materials. J Controlled Release 361:280\u2013296. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.059","journal-title":"J Controlled Release"},{"key":"9189_CR109","doi-asserted-by":"publisher","unstructured":"Lin Y, Yan M, Bai Z et al (2022) Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy. J Nanobiotechnol 20. https:\/\/doi.org\/10.1186\/S12951-022-01636-X","DOI":"10.1186\/S12951-022-01636-X"},{"key":"9189_CR110","doi-asserted-by":"publisher","unstructured":"Kou M, Huang L, Yang J et al (2022) Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis 13. https:\/\/doi.org\/10.1038\/S41419-022-05034-X","DOI":"10.1038\/S41419-022-05034-X"},{"key":"9189_CR111","doi-asserted-by":"publisher","unstructured":"Han Y, Yang J, Fang J et al (2022) The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther 7. https:\/\/doi.org\/10.1038\/S41392-022-00932-0","DOI":"10.1038\/S41392-022-00932-0"},{"key":"9189_CR112","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jare.2024.05.004","volume":"70","author":"CM Trigo","year":"2025","unstructured":"Trigo CM, Rodrigues JS, Cam\u00f5es SP et al (2025) Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? J Adv Res 70:103\u2013124. https:\/\/doi.org\/10.1016\/j.jare.2024.05.004","journal-title":"J Adv Res"},{"key":"9189_CR113","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW et al (2020) Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev 159:332\u2013343. https:\/\/doi.org\/10.1016\/j.addr.2020.04.004","journal-title":"Adv Drug Deliv Rev"},{"key":"9189_CR114","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/S41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G (2021) Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol 16:748\u2013759. https:\/\/doi.org\/10.1038\/S41565-021-00931-2","journal-title":"Nat Nanotechnol"},{"key":"9189_CR115","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/MED.22002","volume":"44","author":"CY Ma","year":"2024","unstructured":"Ma CY, Zhai Y, Li CT et al (2024) Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects. Med Res Rev 44:919\u2013938. https:\/\/doi.org\/10.1002\/MED.22002","journal-title":"Med Res Rev"},{"key":"9189_CR116","doi-asserted-by":"publisher","unstructured":"Han X, Liao R, Li X et al (2025) Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduction and Targeted Therapy 2025 10:1 10:262-. https:\/\/doi.org\/10.1038\/s41392-025-02313-9","DOI":"10.1038\/s41392-025-02313-9"},{"key":"9189_CR117","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/S13287-022-02985-Y","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Gao J, Liang Z et al (2022) Mesenchymal stem cells and their microenvironment. Stem Cell Res Ther 13:429. https:\/\/doi.org\/10.1186\/S13287-022-02985-Y","journal-title":"Stem Cell Res Ther"},{"key":"9189_CR118","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/S41232-023-00266-6","volume":"43","author":"T Manzoor","year":"2023","unstructured":"Manzoor T, Saleem A, Farooq N et al (2023) Extracellular vesicles derived from mesenchymal stem cells \u2014 a novel therapeutic tool in infectious diseases. Inflamm Regen 43:17. https:\/\/doi.org\/10.1186\/S41232-023-00266-6","journal-title":"Inflamm Regen"},{"key":"9189_CR119","doi-asserted-by":"publisher","first-page":"117537","DOI":"10.1016\/J.BIOPHA.2024.117537","volume":"180","author":"Y Li","year":"2024","unstructured":"Li Y, Jin M, Guo D et al (2024) Unveiling the immunogenicity of allogeneic mesenchymal stromal cells: Challenges and strategies for enhanced therapeutic efficacy. Biomed Pharmacother 180:117537. https:\/\/doi.org\/10.1016\/J.BIOPHA.2024.117537","journal-title":"Biomed Pharmacother"},{"key":"9189_CR120","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/JCM10132991","volume":"10","author":"R Sanabria-de la Torre","year":"2021","unstructured":"Sanabria-de la Torre R, Qui\u00f1ones-Vico MI, Fern\u00e1ndez-Gonz\u00e1lez A et al (2021) Alloreactive Immune Response Associated to Human Mesenchymal Stromal Cells Treatment: A Systematic Review. J Clin Med 2021 10:2991. https:\/\/doi.org\/10.3390\/JCM10132991","journal-title":"J Clin Med 2021"},{"key":"9189_CR121","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3390\/CIMB44110351","volume":"44","author":"IV Kholodenko","year":"2022","unstructured":"Kholodenko IV, Kholodenko RV, Majouga AG, Yarygin KN (2022) Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools. Curr Issues Mol Biology 2022 44:5153\u20135172. https:\/\/doi.org\/10.3390\/CIMB44110351","journal-title":"Curr Issues Mol Biology 2022"},{"key":"9189_CR122","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/S13287-023-03472-8","volume":"14","author":"A Tieu","year":"2023","unstructured":"Tieu A, Stewart DJ, Chwastek D et al (2023) Biodistribution of mesenchymal stromal cell-derived extracellular vesicles administered during acute lung injury. Stem Cell Res Ther 14:250. https:\/\/doi.org\/10.1186\/S13287-023-03472-8","journal-title":"Stem Cell Res Ther"},{"key":"9189_CR123","doi-asserted-by":"publisher","first-page":"1211833","DOI":"10.3389\/FCELL.2023.1211833\/FULL","volume":"11","author":"M Cie\u015blik","year":"2023","unstructured":"Cie\u015blik M, Bryniarski K, Nazimek K (2023) Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared? Front Cell Dev Biol 11:1211833. https:\/\/doi.org\/10.3389\/FCELL.2023.1211833\/FULL","journal-title":"Front Cell Dev Biol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09189-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-026-09189-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09189-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:33:52Z","timestamp":1786376032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-026-09189-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9189"],"URL":"https:\/\/doi.org\/10.1007\/s12016-026-09189-9","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"65"}}